Sodium chloride - Mobilisation of lower respiratory tract secretions
You are here : Home > Formulary Search > Sodium chloride - Mobilisation of lower respiratory tract secretions
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Inhalation
- Nebules
Formulary Status :
Restrictions / Comments :
Important
0.9% sodium chloride in 2.5ml unit dose ampoules.
OptimiseRx will be used to inform Primary Care prescribers of the locally preferred, cost effective brand.
Primary Care may prescribe on recommendation from the Respiratory Care Team who will ensure that patients have had suitable training and trial of equipment to ensure safe use.
Status 2
Red
Formulations :
- Inhalation
- Nebules
Formulary Status :
Restrictions / Comments :
Important
3% hypertonic sodium chloride
Status 3
Red
Formulations :
- Inhalation
- Nebules
Formulary Status :
Restrictions / Comments :
Important
6% hypertonic sodium chloride
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Sodium chloride
Indication :
Mobilisation of lower respiratory tract secretions
Group Name :
Keywords :
nebulised saline, hypertonic saline
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
4
Other Indications
Below are listed other indications that Sodium chloride is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Mobilisation of lower respiratory tract secretions.
- No records returned.
Committee Recommendations (1)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.